985-GILZ clones, but phosphorylation and subsequent proteasomal degradation of myeloid cell leukemia-1 (Mcl-1) were observed. Noteworthy, Mcl-1 phosphorylation was related to a significant and sustained activation of c-Jun N-terminal kinase (JNK) in PLB-985-GILZ clones. These results reveal GILZ to be a new actor in apoptosis regulation in neutrophil-like cells involving JNK and Mcl-1.
Glucocorticoid-Induced Leucine Zipper Is Expressed in Human Neutrophils and Promotes Apoptosis through Mcl-1 Down-Regulation
oxygen species generated upon NADPH oxidase activation could participate in the control of the decision between necrosis, apoptosis or cell survival [4] . Mcl-1 is unique among Bcl-2 family members in that it is essential for the survival of several cell lineages, particularly neutrophils, as has been demonstrated in vitro but also in vivo [5] . Indeed, Mcl-1 conditional knockout (KO) mice show a severely impaired survival of mature neutrophils in the periphery [6] . Mcl-1 expression is regulated at transcriptional, post-transcriptional and post-translational levels, affecting its stability and functions [5] . Notably, phosphorylation by the coordinated activity of c-Jun Nterminal kinase (JNK) and glycogen synthase kinase 3 (GSK3) mediates the proteasomal degradation of Mcl-1 and the rapid triggering of cell death [7] . Glucocorticoid-induced leucine zipper (GILZ), an anti-inflammatory and immunomodulatory protein belonging to the transforming growth factor-β stimulating clone 22 domain (TSC-22D) family, has been shown to be rapidly induced upon treatment with glucocorticoids (GCs), particularly in haematopoietic cells [8] . Initially, the anti-inflammatory and immunomodulatory effects of GILZ were extensively described in vitro and were mostly related to the inhibition of activator protein-1 (AP-1) and nuclear factor-kappa B (NF-κB) transcription factors [8] . More recently, inhibition of colitis development was observed in vivo using TAT-GILZ fusion protein delivery in dinitrobenzene sulfonic acid-treated IL-10 KO mice, demonstrating in vivo that GILZ could present therapeutic potential [8] . In addition, GILZ plays a pivotal role in controlling cell survival and apoptosis. Indeed, GILZ inhibits activation-induced cell death (AICD) in 3D0 hybridoma T cells [8] . Furthermore, our group demonstrated that in T lymphocytes, GILZ prevents IL-2 deprivation-mediated apoptosis through forkhead box O3 (FOXO3) inhibition and consequent Bcl-2 interacting mediator of cell death (Bim) down-regulation [9] . On the contrary, GILZ induces apoptosis in some cell types such as thymocytes, involving a downregulation of Bcl-xL expression and caspase-8 and caspase-3 activations [10] . More recently, GILZ was shown to promote apoptosis in chronic myeloid leukemia cells expressing BCR-ABL oncoprotein. In this model, GILZ specifically binds to mTORC2, leading to the inhibition of AKT phosphorylation, FOXO3 transcriptional activation and Bim expression [11] . Altogether, these results highlight that GILZ regulations and functions are particularly dependent on the cell types. Our aim was first to document GILZ expression in neutrophils, and second to evaluate its role in apoptosis.
In this study, we observed the induction of GILZ expression in human blood neutrophils, which could promote apoptosis of these cells. To specifically address GILZ functions in this setting, we used the human promyelocytic leukemia PLB-985 cell line stably transfected with the human gilz gene and differentiated into neutrophillike cells. We found that GILZ overexpression led to an exacerbated apoptosis, involving the mitochondrial pathway and associated with a sustained activation of JNK and the down-regulation of Mcl-1.
Materials and Methods

Chemicals and Reagents
All-trans retinoic acid (ATRA), 2 ′ ,7 ′ -dichlorofluorescin diacetate (DCFH-DA), 3,3 ′ -dihyloxacarbocyanine iodide (DiOC 6 ), the JNK inhibitor SP600125 and the GSK3 inhibitor SB216763 were obtained from Sigma-Aldrich (Lyon, France). Antibodies for flow cytometry (CD11b and mouse IgG1), the BD kit Cytofix/Cytoperm TM and annexin V/7AAD were obtained from BD Biosciences (San José, Calif., USA). Fluorescein-conjugated zymosan A was obtained from Invitrogen (Cergy-Pontoise, France). N,N-dimethylformamide (DMF) was obtained from Carbo Erba (Rodano, Italy). The pan-caspase inhibitor Q-VD-OPh was from Biovision (Mountain View, Calif., USA). HBSS was obtained from Gibco Life Technologies (Saint Aubin, France) and the proteasome inhibitor MG-262 from Merck-Millipore (Nottingham, UK). Dexamethasone (DEX) was purchased from Sigma-Aldrich (St Louis, Mo., USA). LY294002 was purchased from Calbiochem.
Neutrophil Isolation
Neutrophils were isolated from healthy donors' peripheral blood provided by the Etablissement Français du Sang (Rungis, France). Whole-blood centrifugation (20 min at 690 g and 20 ° C) on lymphocyte separation medium (Eurobio, Les Ulis, France) was used to separate PBMC (supernatant) from neutrophils and erythrocytes (pellet). Neutrophils were then isolated by pellet sedimentation on 5% dextran T500 (Pharmacia, Uppsala, Sweden) in 0.9% saline at a ratio of 4: 1. Contaminating erythrocytes were removed by hypotonic lysis, and neutrophils (consistently >95% pure) were resuspended in RPMI-1640 medium, containing 0.1 mg/ml streptomycin, 100 U/ml penicillin, 1% sodium pyruvate (Fisher Scientific, Illkirch, France) and 10% foetal calf serum (PAA, Les Mureaux, France).
PLB-985 Culture and Differentiation
The human myeloid leukemia cell line PLB-985 was maintained in RPMI-1640 medium, containing 0.1 mg/ml streptomycin, 100 U/ml penicillin, 1% sodium pyruvate (Fisher Scientific, Illkirch, France) and 10% fetal calf serum (PAA). Cells were maintained at a density of between 0.1 and 1 × 10 6 /ml. For granulocytic differentiation, exponentially growing cells at a starting density of 3 × 10 5 /ml were cultured in RPMI-1640 supplemented with 0.5% DMF (Carbo Erba), 1 μ M ATRA, 1% sodium pyruvate and 5% foetal calf serum. The medium was changed once on day 3 during the 5 days differentiation period and cells were adjusted to 1 × 10 6 /ml [12] . On day 5, granulocytic differentiation was assessed by the measure of CD11b cell surface expression and hydrogen peroxide (H 2 O 2 ) production as described below. Cell viability was assessed before experiments by trypan blue exclusion and was routinely >95%.
Plasmid Constructs and Transfection pcDNA3-Myc and pcDNA3-Myc-GILZ constructs were described previously [9] . PLB-985 cells were transfected with pcDNA3-Myc or pcDNA3-Myc-GILZ using an AMAXA system, program U015 in dendritic cells buffer (Amaxa, La Ferte Mace, France). Four million cells were transfected with 4 μg of plasmid. A selection of stably transfected cells was initiated 48 h after electroporation using 1.2 mg/ml G418 (Fisher Scientific). Cells were then cloned by limiting dilution.
Phenotypic Analysis of Differentiated PLB-985 Cells 3 × 10
5 differentiated PLB-985 cells were washed once in PBS and incubated in PBS containing 0.05% BSA for 30 min at 4 ° C with anti-CD11b-PE (phycoerythrin) and appropriate antibody isotypes, i.e. mouse IgG1 (both from BD Biosciences). Cells were then washed twice in PBS 0.05% BSA, once in PBS and fixed in PBS + 1% formaldehyde. For each sample, 10,000 cells were acquired from a gated homogenous cell population using a FACSCalibur flow cytometer (BD Biosciences) and results were analyzed using the CellQuest software. Results were expressed as the mean fluorescence intensity (MFI) of cells labeled with antigen-specific antibody divided by the MFI of isotype labelled cells.
Hydrogen Peroxide Production
As previously described [9] , H 2 O 2 production of differentiated PLB-985 cells (10 6 /ml in HBSS) was measured by flow cytometry after preincubation with 1.25 μ M DCFH-DA and stimulation for 15 min at 37 ° C with 50 ng/ml PMA (both from Sigma-Aldrich). A stimulation index (termed 'fold induction') was calculated as the MFI ratio of PMA-treated cells versus unstimulated cells.
Phagocytosis Assay
Fluorescein-conjugated zymosan A (Invitrogen) particles were opsonised by incubation for 1 h at 37 ° C in pooled and decomplemented human sera diluted by half with PBS. Particles were then washed 3 times in PBS. Differentiated PLB-985 cells (5 × 10 6 /ml) were then incubated for 30 min at 37 ° C with the particles. The ratio of 10 particles per cell was found optimal. Synchronization of the interaction between cells and particles was achieved by rapidly sedimenting the cells together with zymosan particles. Phagocytosis was stopped by adding cold PBS and trypan blue (1.2 mg/ml final concentration) to quench the fluorescence of the non-ingested particles that remain associated with the cells. Cells were also incubated with zymosan particles at 4 ° C as a negative control. The percentage of phagocytic cells was determined using a FACSCalibur flow cytometer. Annexin-V Externalization and DNA Hypodiploidy Apoptosis was determined using flow cytometry by quantification of DNA hypodiploidy (sub-G1 peak) as previously described [9] , and by quantification of annexin-V-positive cells. Harvested cells were incubated with annexin-V-PE and 7-aminoactinomycin D (7-AAD) according to the manufacturer's protocol (BD Biosciences). Data acquisition was performed using the CellQuest software (BD Biosciences). bands were detected by chemiluminescence using a ChemiDoc XRS+ system (Bio-Rad, Marnes la Coquette, France). Bands were quantified using ImageLab software. Results were expressed as the ratio of the protein of interest to β-tubulin or JNK.
Apoptosis Measurements
Immunoblotting
Real-Time PCR Analysis
PLB-985 cells were frozen at different times along differentiation in RNA Plus TM (MP Biomedicals). Total RNA was isolated according to the manufacturer's protocol. Reverse transcription and real-time PCR were conducted as previously described [13] using the SYBR Green technology on a Bio-Rad CFX96 system. Briefly, we used SsoAdvanced EvaGreen supermix (Bio-Rad) and primers for mcl-1
The quantification was performed with the Bio-Rad CFX Manager software, and data were analyzed using the ΔΔCt method. Ratio was calculated as the geometrical mean of (1 + E) -ΔΔCt values, where E is the efficiency and ΔΔCt is the target gene expression of treated cells compared with normal levels in untreated cells and corrected using the expression of the reference genes gapdh and b2m . Results were expressed as variation compared to wild-type (WT) cells, i.e. the ratio of (1 + E) − ΔΔCt of clone cells/(1 + E) − ΔΔCt of WT cells.
Statistical Analysis
Experiments were performed at least 3 times and results were presented as mean ± standard error of the mean (SEM). The Mann-Whitney U test was used to compare pairs of means (generally 'Myc' group versus 'GILZ' group). Results were considered significant when p < 0.05. Statistical analyses were performed with GraphPad Prism software (San Diego, Calif., USA).
Results
GILZ Is Expressed in Human Blood Neutrophils
GCs are among the most widely used treatments for inflammatory diseases and are also the best characterized inducers of GILZ in hematopoietic cells such as thymocytes, peripheral T cells [8, 14] or dendritic cells [15] . In freshly isolated human neutrophils treated for 12 h with increasing concentrations (10 -9 , 10 -8 , 10
-7 M ) of DEX, gilz expression was induced in a dose-dependent manner at the mRNA ( fig. 1 a) and protein levels ( fig. 1 b, d ). Moreover, the proteasome inhibitor MG262 caused a marked accumulation of GILZ in the absence of DEX, and more substantially in the presence of DEX ( fig. 1 b) , suggesting that GILZ could be subject to proteasomal degradation.
GCs are known to paradoxically inhibit the apoptosis of human neutrophils, at least in part, through the upregulation of the antiapoptotic protein Mcl-1 [16] . Inhibition of the phosphatidylinositol 3-kinase (PI3K) signalling pathway was shown to reduce neutrophil survival and Mcl-1 expression in the presence of DEX [16] . Neutrophils were then treated with DEX and LY294002, a potent, cell-permeable inhibitor of PI3K, and both GILZ expression and apoptosis were evaluated. Results showed that inhibition of the PI3K pathway enhanced gilz induction with suboptimal concentrations of 10 -9 and 10 -8 M of DEX ( fig. 1 c) . Moreover, LY294002 suppressed GC-induced Mcl-1 while efficiently promoting GILZ expression at the suboptimal concentrations of 10 -9 and 10 -8 M of DEX ( fig. 1 d) . Interestingly, LY294002 also partly abrogated DEX-induced neutrophil survival as assessed by sub-G1 analysis ( fig. 1 e) , suggesting that upon GC stimulation, apoptosis of neutrophils could depend on the balance between GILZ and Mcl-1 expressions. In the absence of Mcl-1, GILZ could promote apoptosis. To test this hypothesis without GC stimulation, which is known to regulate the expression of numerous target genes, and because neutrophils cannot be subject to genetic manipulation, we decided to stably transfect a GILZ expression vector in the neutrophil-like PLB-985 cells and to investigate apoptosis in this model once differentiation had taken place. 
GILZ Expression Does Not Affect PLB-985 Cell Differentiation
Human neutrophils are short-lived, terminally differentiated cells which cannot be genetically modified. Once differentiated, PLB-985 cells share many functional features with peripheral-blood mature neutrophils and are therefore widely used to study the molecular mechanisms of neutrophil biology [12, 17] . Interestingly, in these cells, GILZ was not detected in undifferentiated cells and strongly induced by a 2-to 3-hour treatment with GCs fig. 1 d) .
To specifically investigate the role of GILZ expression in these cells, we generated GILZ overexpressing clones stably transfected with the human gilz gene (PLB-GILZ clones) and control clones (PLB-Myc) transfected with the empty vector ( fig. 2 b) . GILZ clones were selected based on GILZ expression and control clones were selected by comparison with WT cells (PLB-985-WT). GILZ expression was found to be cytoplasmic in PLB- Apoptosis was quantified using the sub-G1 technique. PLB-GILZ clones were significantly more apoptotic from day 3 to day 7. Mann-Whitney U test. * p < 0.05, # p < 0.01. The results represent the means ± SEM of 4 independent experiments. d Measurement of mitochondrial potential in PLB-Myc and PLB-GILZ clones. PLB-Myc clones (full lines) and PLB-GILZ clones (broken lines). Cells were loaded with 100 μ M DiOC 6 for 1 h, and the mitochondrial potential was followed using cytofluorometry. The difference was statistically significant using the Mann-Whitney U test on days 4-7. * p < 0.05. The results represent the means ± SEM of 4 independent experiments. e Comparison of mitochondrial potential loss in PLB-Myc and PLB-GILZ clones. Slopes were determined from the observed kinetics of each clone. PLB-GILZ clones slope values were statistically higher than those of PLB-Myc clones. Mann-Whitney U test. 88 GILZ clones (data not shown), as previously described in the laboratory in HL-60 cells [18] . PLB-985 cells can be differentiated in vitro in neutrophil-like cells using ATRA and DMF [12, 17] . After 5 days of differentiation, no difference in CD11b expression was observed in PLB-GILZ compared with PLB-Myc clones and PLB-985-WT cells as expressed by the MFI ( fig. 2 c) or percentage of CD11b-positive cells ( fig. 2 d) . Basal CD11b cell surface expression in WT or PLB clones on day 5 of differentiation was similar to that obtained with neutrophils freshly isolated from human blood (data not shown), reflecting the terminal granulocytic maturation of these cells. In the absence of stimulation, PLB-Myc and PLB-GILZ clones had comparable intracellular basal levels of reactive oxygen species, as assessed by DCFH-DA oxidation (online suppl. data 1; for all online suppl. material, see www.karger.com/doi/10.1159/000439052). Using a gate restricted to viable cells (in order not to analyze apoptotic cells), H 2 O 2 production in response to PMA was similar in the PLB-GILZ and PLB-Myc control clones ( fig. 2 e) . Finally, the phagocytosis of fluorescein-conjugated zymosan particles was similar in PLB-Myc and PLB-GILZ differentiated clones ( fig. 2 f) . Altogether, these results indicate that differentiated PLB-985 cells provide a neutrophil-like model suitable for evaluating GILZ functions in neutrophils. Day 5 of differentiation was chosen for further functional experiments, since we observed the highest basal CD11b expression ( fig. 2 d) .
Expression of GILZ Promotes Apoptosis in PLB-985 Differentiated Cells
Circulating neutrophils enter spontaneously into apoptosis as terminally differentiated cells [2] . Differentiated PLB-985 cells also undergo apoptosis when their differentiation is completed. So we evaluated whether GILZ expression could alter their spontaneous apoptosis process. The sub-G1 analysis showed that, on day 5 of differentiation, GILZ expression led to an exacerbated apoptosis in all the clones tested ( fig. 3 a) . A representative dot plot of annexin V/7AAD staining for the clones M10 and G48 is presented in figure 3 b, showing that GILZ-overexpressing cells are mainly early apoptotic (annexin V+/7AAD-) with few cells in secondary necrosis (annexin V+/7AAD+); no primary necrotic cells were detected (annexin V-/7AAD+). Furthermore, to better characterize the kinetics of apoptosis, DNA hypodiploidy was followed during differentiation in representative clones. We observed that apoptosis started after 3 days of differentiation in PLB-GILZ G2 and G48 clones and to a much lesser extent in control clones ( fig. 3 c) . Apoptosis was significantly increased in PLB-GILZ G2 and G48 clones at day 4 and day 5 when compared to control M4 and M10 clones, suggesting that GILZ overexpression could probably accelerate or strengthen the spontaneous apoptosis process initiated by differentiation.
Alteration of Mitochondrial Potential in PLB-GILZ Clones
Loss of mitochondrial potential is a hallmark of the classic pathway of apoptosis. Using DiOC 6 staining and flow cytometry analysis, a significant increase in mitochondrial potential alteration was found in PLB-GILZ clones compared to PLB-Myc clones. This loss of mitochondrial potential was found earlier in PLB-GILZ clones ( fig. 3 d) , as shown by the slope calculated from each clone kinetics ( fig. 3 e) , consistent with the sub-G1 kinetics reported above.
Apoptosis of PLB-GILZ Clones Is Caspase-Dependent
Caspases are key players in neutrophil apoptosis [4] . To clarify whether caspases were involved in GILZinduced exacerbation of PLB-985 apoptosis, cells were treated from day 3 to day 5 of differentiation with a pancaspase inhibitor, Q-VD-OPh, which is more potent, more specific and less cytotoxic (even at high concentrations) than z-VAD-fmk [19] . Results showed that Q-VDOPh treatment strongly prevented apoptosis in both PLB-Myc and PLB-GILZ clones ( fig. 4 a) , suggesting that caspases are involved in GILZ-related apoptosis.
PLB-Myc and PLB-GILZ clones were differentiated for 5 days and caspase-9, caspase-3 and caspase-8 activations were followed using Western blot and flow cytometry. We found the highest activation of caspase-9 at day 5 of differentiation in PLB-GILZ clones compared to control clones, although this did not reach statistical significance ( fig. 4 b, c) . A significant increase of procaspase-3 cleavage was observed by Western blot in PLB-GILZ clones compared to PLB-Myc clones ( fig. 4 b, d) , with a marked detection of the active p23 subunit. These results were confirmed by flow cytometry using an antibody against p23 ( fig. 4 e) . Interestingly, GILZ expression induced an earlier caspase-3 activation during differentiation, consistent with the hypothesis of an acceleration of the apoptosis process in these cells. Differences were evident from day 4 by flow cytometry ( fig. 4 e) and from day 5 by Western blot (online suppl. data 2), reflecting the different sensitivities of these 2 techniques. Finally, results obtained by flow cytometry showed a late but noteworthy activation of caspase-8 in PLB-GILZ clones that was statistically significant compared to PLB-Myc clones on day 7 of differentiation ( fig. 4 f) . WT  M3  M4  M9  M10  G2  G7  G11  G19  G24 . Caspase-3 activation was monitored using flow cytometry with an antibody directed to the p23 active form of caspase-3. Differences were statistically significant using the Mann-Whitney U test on days 4-7. * p < 0.05. The results represent the means ± SEM of 4 independent experiments. f Activation of caspase-8 in PLB-Myc and PLB-GILZ clones. PLB-Myc clones (full lines) and PLB-GILZ clones (broken lines). Caspase-8 activation was followed with FITC-conjugated IETD-FMK and cytofluorometry. Differences were observed on day 7 of differentiation but not on day 5 (statistically significant using the Mann-Whitney U test). WT  M3  M4  M9  M10  G2  G7  G11  G19  G24 the pharmacologic inhibitor of JNK (SP600125) at 10 μ M . Apoptosis was evaluated using sub-G1 analysis on day 5 of differentiation. Results showed that SP600125 efficiently and significantly reduced the induction of apoptosis of PLB-GILZ clones ( fig. 8 d) , confirming the role of JNK in the apoptosis due to GILZ overexpression.
Discussion
GILZ is a protein that is rapidly expressed upon treatment with GCs and is believed to relay part of the antiinflammatory and immunomodulatory effects of GCs [23] . GILZ is also involved in cell survival, by exerting pro-or anti-apoptotic effects, depending on the cell type and the stimuli used [9, 11, 24] . In this work, we specifically addressed the role of GILZ expression on neutrophil functions, with a special emphasis on apoptosis. We demonstrated that GILZ was induced by GCs in human neutrophils and could be subject to proteasomal degradation, allowing its levels to change quickly in response to some specific stimuli. The combination of DEX and an inhibitor of the PI3K signalling pathway up-regulated GILZ levels, as previously described in multiple myeloma cells [25] and lung epithelial cells [26] or, more recently, in normal human lung fibroblasts [27] . The gilz promoter, which was characterized in the laboratory [9] , comprises 6 GC-responsive elements and 3 FOXO responsive elements which functionally cooperate for optimal activation of the promoter [14] . Here, interruption of the PI3K/ Akt pathway using pharmacological inhibitors could result in the activation of FOXO proteins. Concomitant DEX and LY294002 treatment was linked with the enhanced apoptosis of neutrophils, associated with GILZ up-regulation and the inhibition of Mcl-1 induction. Altogether, these results suggest that upon GC stimulation, apoptosis of neutrophils could be controlled by the relative expressions of GILZ and Mcl-1. In the absence of Mcl-1, GILZ could shift the balance in favour of apoptosis. It was recently suggested that, even if GCs are known to delay neutrophil apoptosis in vitro, thereby paradoxically limiting the control of neutrophilic inflammation, some conditions at inflamed sites (severe hypoxia or inflammatory mediators) could create a microenvironment where a neutrophil pro-survival effect is abrogated [28] . We cannot exclude that GILZ expression could be favoured and locally promoted in vivo in such specific microenvironments.
To specifically address the role of GILZ in neutrophils, we stably expressed the human gilz gene in the PLB-985 cell line that differentiates into fully mature and functional neutrophil-like cells [12, 29] . After granulocytic differentiation, PLB-985 cells were shown to express neutrophil-like surface markers, become responsive to physiological neutrophil stimuli such as fMLP or TNF-α [17, 30, 31] and display functional characteristics such as calcium mobilization, granule exocytosis as well as phagocytosis [32] . GILZ expression in PLB-985 cells did not alter PLB-985 cell differentiation kinetics after ATRA and DMF addition, CD11b basal expression, phagocytosis or PMA-induced oxidative burst. Upon differentiation, PLB-985 cells undergo apoptotic cell death and can therefore be used as a model of apoptosis of resting neutrophils [29] . This apoptotic process was observed from the third day of differentiation. Noteworthy, when GILZ was overexpressed in PLB-985 cells, a significant increase of apoptosis was found in PLB-GILZ clones compared to PLB-Myc clones, strongly suggesting that GILZ could provoke apoptosis or take part in the spontaneous apoptotic process in these cells. It is generally admitted that neutrophils can engage the intrinsic or the extrinsic death pathways resulting in the activation of effector caspases [4] . Particularly, in neutrophils undergoing spontaneous apoptosis, caspase-3 is known to be activated in a time-dependent manner and to play a central role in the execution of the apoptotic process. Apoptosis of PLB-Myc and PLB-GILZ cells was caspase-dependent, significantly abrogated by the pan-caspase inhibitor QVD-OPh and characterized by an earlier activation of the same caspases (caspase-9 and caspase-3). In PLB-GILZ cells, caspase-8 activation occurred 2 days after the detectable activation of caspase-3, suggesting that its activation was not direct. Active caspase-3 could induce late activation of caspase-8 as an amplification loop, as found in other cell types [33] . Neutrophils display few mitochondria, which hardly participate in ATP synthesis. Nevertheless, the mitochondrial death pathway is functional in these cells, probably due to elevated cytoplasmic Apaf-1 levels [2] . Our results showed an alteration of the mitochondrial potential in PLB-GILZ clones, and the kinetics of mitochondrial potential loss and caspase-3 activation were quite similar. Altogether, these results suggest that apoptosis of PLB-GILZ clones involved an exacerbated activation of the mitochondrial pathway.
Under non-stimulated conditions, human neutrophils constitutively express relatively stable levels of pro-apoptotic proteins such as Bax, Bak, Bim or Bid [4, 34] . Thus, neutrophil apoptosis and survival might be controlled essentially by the inducible expression or degradation of the anti-apoptotic protein Mcl-1, whereas the levels of the proapoptotic proteins Bax, Bad, Bik, and Bak remain constant [35] . Our results showed similar modulation of Bax and Bid expressions in PLB-GILZ and PLB-Myc cells. In contrast, we observed a down-regulation of Bim in PLB-GILZ cells, confirming our previous results in T cells [9, 18] . The unconformity between Bim expression levels and apoptosis found here has been already described, as inhibition of apoptosis has been reported in neutrophils despite increased Bim levels [36] . Altogether, these results suggest that in our model, the balance between death and survival signals was still in favour of apoptosis despite Bim down-regulation, probably due to alteration in the expression of anti-apoptotic proteins.
Mcl-1 is a labile and inducible anti-apoptotic protein essential in the control of neutrophil life span [5] . Our results showed that GILZ probably modulated Mcl-1 expression through a post-translational modification since mcl-1 mRNA levels were not affected. Stability of Mcl-1 is controlled by phosphorylations of serine and threonine residues present in the N-terminal-domain PEST sequence, which is associated with the targeting of proteins to the proteasome for rapid turnover [7] . In murine fibroblasts, stress-induced apoptosis is associated with Mcl-1 degradation requiring the coordinated activity of JNK and GSK3 [37] . Thus, we hypothesized that GILZ expres-sion could lead to Mcl-1 phosphorylation through JNK activation.
We observed a sustained increase of JNK phosphorylation in PLB-GILZ cells, as soon as 3 days of differentiation and statistically significant by day 5, concomitant with Mcl-1 degradation. Since PLB-Myc and PLB-GILZ clones had similar intracellular levels of reactive oxygen species after 5 days of differentiation, we excluded excessive oxidative stress due to GILZ expression. JNK activation is regulated by the MKP-1 phosphatase, known to be regulated by GILZ in a human endothelial cell line [38, 39] , but its expression was similar in the course of differentiation of PLB-Myc and PLB-GILZ clones.
We are proposing an original mechanism of neutrophil apoptosis where GILZ expression leads to JNK activation and phosphorylation of Mcl-1, its subsequent degradation by the proteasome and, consequently, apoptosis. This hypothesis was confirmed by the specific detection of JNK-and GSK3-phosphorylated Mcl-1 under proteasome inhibition in PLB-GILZ cells and by reduced apoptosis of these cells in the presence of the JNK inhibitor SP600125. JNK activation is known to contribute to apoptotic signalling [40] , as in normally cycling cells at the G 2 /M phase or in presence of microtubule-damaging drugs such as paclitaxel, through the phosphorylation of Bcl-2, resulting in its inactivation [41] . Furthermore, it has been described that a sustained activation of JNK is associated with apoptosis, particularly in cells where the apoptotic program has been initiated, whereas the acute and transient activation of JNK may be involved in the proliferation or survival of cells [40] . Indeed, prolonged JNK activation was shown to play a pro-apoptotic role in the UV-induced apoptosis of fibroblasts, through the mitochondrial death pathway [42] . Here, sustained JNK activation promoted Mcl-1 phosphorylation and degradation, and apoptosis in neutrophil-like cells.
In this work, we show for the first time that GILZ is expressed in human neutrophils and that this expression, in a recognized cellular model of neutrophil-like cells, enhances spontaneous apoptosis through JNK activation and Mcl-1 down-regulation. We propose here a new mechanism of neutrophil apoptosis regulation by GILZ, the relevance of which in clinical inflammatory settings remains to be thoroughly evaluated. Interestingly, consistent with our in vitro observations reported here, it was very recently described in an LPS-induced pleurisy model in mice that the administration of a TAT-GILZ protein promoted resolution of neutrophilic inflammation [43] .
